Heinz Wiendl Selected Research

Epilepsy (Aura)

3/2022	A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies.
10/2021	Diagnostic utility of cerebrospinal fluid (CSF) findings in seizures and epilepsy with and without autoimmune-associated disease.
11/2019	Human CCR5high effector memory cells perform CNS parenchymal immune surveillance via GZMK-mediated transendothelial diapedesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Heinz Wiendl Research Topics

Disease

143	Multiple Sclerosis 11/2022 - 01/2002
39	Relapsing-Remitting Multiple Sclerosis 01/2022 - 10/2008
33	Inflammation (Inflammations) 01/2021 - 11/2003
21	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2019 - 11/2003
19	Neoplasms (Cancer) 03/2022 - 05/2002
15	Progressive Multifocal Leukoencephalopathy 01/2022 - 02/2011
15	Neuroinflammatory Diseases 01/2022 - 07/2007
13	Infections 04/2022 - 04/2011
11	Myositis (Idiopathic Inflammatory Myopathies) 01/2022 - 05/2003
11	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 11/2008
9	Disease Progression 05/2022 - 09/2008
9	Myasthenia Gravis 04/2022 - 01/2019
9	Glioma (Gliomas) 01/2020 - 05/2002
8	Demyelinating Diseases (Demyelinating Disease) 12/2021 - 11/2003
7	Deglutition Disorders (Dysphagia) 01/2022 - 01/2019
7	Rheumatoid Arthritis 01/2018 - 08/2007
7	Encephalitis (Encephalitis, Rasmussen) 04/2016 - 07/2006
6	COVID-19 05/2022 - 01/2020
6	Neuromyelitis Optica (Devic's Disease) 05/2022 - 01/2015
6	Ischemic Stroke 01/2020 - 06/2014
6	Stroke (Strokes) 01/2020 - 01/2009
6	Central Nervous System Diseases (CNS Diseases) 01/2017 - 09/2009
6	Rhabdomyosarcoma 11/2008 - 07/2002
5	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 03/2022 - 01/2015
5	Brain Diseases (Brain Disorder) 01/2022 - 06/2015
5	Polymyositis 12/2015 - 07/2002
4	Primary angiitis of the central nervous system 01/2021 - 01/2018
4	Infarction (Infarctions) 01/2020 - 01/2009
4	Autoimmune Diseases of the Nervous System 01/2019 - 04/2016
3	Epilepsy (Aura) 03/2022 - 11/2019
3	Seizures (Absence Seizure) 03/2022 - 07/2019
3	Virus Diseases (Viral Diseases) 02/2022 - 01/2020
3	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 05/2002
3	Leukocytosis (Pleocytosis) 10/2021 - 11/2005
3	Exanthema (Rash) 08/2021 - 10/2015
3	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2019
3	HIV Infections (HIV Infection) 10/2020 - 03/2014
3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 11/2005
3	Cognitive Dysfunction 11/2019 - 01/2017
3	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2019 - 07/2017
3	Atrophy 01/2019 - 07/2012
3	Necrosis 01/2018 - 01/2002
3	Chronic Progressive Multiple Sclerosis 10/2017 - 11/2005
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2017 - 01/2009
3	Brain Ischemia (Cerebral Ischemia) 02/2013 - 01/2010
2	Paraparesis 05/2022 - 02/2021

Drug/Important Bio-Agent (IBA)

35	Natalizumab (Tysabri)FDA Link 01/2022 - 06/2007
25	AntibodiesIBA 04/2022 - 11/2003
25	Alemtuzumab (Campath)FDA Link 01/2022 - 01/2012
20	Proteins (Proteins, Gene)FDA Link 12/2021 - 07/2002
18	AntigensIBA 01/2022 - 01/2002
16	Monoclonal AntibodiesIBA 01/2022 - 01/2002
15	CytokinesIBA 12/2018 - 01/2002
15	HLA-G Antigens (HLA G)IBA 01/2017 - 05/2002
11	Fingolimod Hydrochloride (FTY720)FDA Link 01/2022 - 06/2012
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2013
10	Cladribine FDA LinkGeneric 11/2022 - 01/2002
10	Pharmaceutical PreparationsIBA 01/2022 - 07/2007
10	Myelin-Oligodendrocyte GlycoproteinIBA 12/2021 - 11/2003
10	Potassium Channels (Potassium Channel)IBA 07/2015 - 05/2008
9	Messenger RNA (mRNA)IBA 05/2022 - 05/2002
9	Rituximab (Mabthera)FDA Link 01/2022 - 01/2008
8	AutoantibodiesIBA 03/2022 - 01/2017
8	teriflunomideIBA 01/2022 - 03/2014
8	LigandsIBA 11/2019 - 01/2002
7	Immunoglobulin G (IgG)IBA 01/2022 - 01/2019
6	TabletsIBA 11/2022 - 10/2017
6	Dimethyl FumarateIBA 02/2022 - 02/2016
6	Transcription Factors (Transcription Factor)IBA 01/2021 - 10/2006
6	HLA-DR Antigens (HLA-DR)IBA 01/2021 - 05/2003
6	Interferon-betaIBA 09/2015 - 10/2004
5	Protein Isoforms (Isoforms)IBA 03/2022 - 01/2015
5	Integrin alpha4beta1 (VLA-4)IBA 08/2018 - 06/2007
4	VaccinesIBA 05/2022 - 01/2021
4	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 03/2022 - 04/2016
4	HLA Antigens (Human Leukocyte Antigens)IBA 03/2022 - 01/2018
4	ofatumumab FDA Link 01/2022 - 01/2020
4	eculizumab FDA Link 01/2022 - 01/2020
4	ocrelizumabIBA 01/2022 - 01/2021
4	Interferon beta-1a FDA Link 12/2021 - 10/2015
4	InterferonsIBA 12/2021 - 04/2016
4	Intravenous Immunoglobulins (IVIG)FDA Link 08/2021 - 01/2002
4	Cholinergic ReceptorsIBA 05/2021 - 01/2019
4	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 01/2018
4	IntegrinsIBA 01/2019 - 06/2014
4	Daclizumab (Zenapax)FDA Link 01/2019 - 07/2013
4	Glatiramer Acetate (Copaxone)FDA Link 04/2016 - 01/2012
4	Peptides (Polypeptides)IBA 07/2014 - 01/2002
3	Interleukin-2 (IL2)IBA 01/2022 - 07/2013
3	Neuroprotective AgentsIBA 01/2020 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2018 - 01/2002
3	Laminin (Merosin)IBA 08/2018 - 12/2010
3	SaltsIBA 01/2018 - 02/2016
3	EnzymesIBA 01/2018 - 01/2015
3	Blood Coagulation Factors (Coagulation Factor)IBA 01/2018 - 12/2016
3	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2016 - 08/2010
3	AcidsIBA 04/2011 - 05/2008
2	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2022 - 01/2022

Therapy/Procedure

69	Therapeutics 01/2022 - 01/2002
13	Immunotherapy 05/2022 - 12/2008